(Q31145409)

English

The ReSPonD trial--rivastigmine to stabilise gait in Parkinson's disease a phase II, randomised, double blind, placebo controlled trial to evaluate the effect of rivastigmine on gait in patients with Parkinson's disease who have fallen

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

The ReSPonD trial--rivastigmine to stabilise gait in Parkinson's disease a phase II, randomised, double blind, placebo controlled trial to evaluate the effect of rivastigmine on gait in patients with Parkinson's disease who have fallen (English)

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Parkinson's disease

0 references

phase II clinical trial

0 references

0 references

Yoav Ben-Shlomo

6

0 references

object named as

Alan Whone

5

0 references

Stephen R. Lord

object named as

Stephen R Lord

2

0 references

Emily J Henderson

object named as

Emily J Henderson

1

1 reference

ORCID Public Data File 2021

Jacqueline C. T. Close

3

object named as

Jacqueline C T Close

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

author name string

Andrew D Lawrence

4

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

publication date

3 December 2013

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

13

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

188

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Derivation and validation of updated QFracture algorithm to predict risk of osteoporotic fracture in primary care in the United Kingdom: prospective open cohort study

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3880104

21 June 2018

https://api.crossref.org/works/10.1186%2F1471-2377-13-188

21 January 2018

Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3880104

21 June 2018

A review of dual-task walking deficits in people with Parkinson's disease: motor and cognitive contributions, mechanisms, and clinical implications

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3880104

21 June 2018

The MoCA: well-suited screen for cognitive impairment in Parkinson disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3880104

21 June 2018

A recommended scale for cognitive screening in clinical trials of Parkinson's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3880104

21 June 2018

Effects of a central cholinesterase inhibitor on reducing falls in Parkinson disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3880104

21 June 2018

Cholinergic mesencephalic neurons are involved in gait and postural disorders in Parkinson disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3880104

21 June 2018

History of falls in Parkinson disease is associated with reduced cholinergic activity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3880104

21 June 2018

Can cognitive enhancers reduce the risk of falls in older people with mild cognitive impairment? A protocol for a randomised controlled double blind trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3880104

21 June 2018

Self administered cognitive screening test (TYM) for detection of Alzheimer's disease: cross sectional study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3880104

21 June 2018

Fear of falling is independently associated with recurrent falls in patients with Parkinson's disease: a 1-year prospective study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3880104

21 June 2018

Can cognitive enhancers reduce the risk of falls in people with dementia? An open-label study with controls

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3880104

21 June 2018

Determinants of disability and quality of life in mild to moderate Parkinson disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3880104

21 June 2018

FRAX and the assessment of fracture probability in men and women from the UK

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3880104

21 June 2018

A meta-analysis of six prospective studies of falling in Parkinson's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3880104

21 June 2018

Effect of rivastigmine on delay to diagnosis of Alzheimer's disease from mild cognitive impairment: the InDDEx study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3880104

21 June 2018

Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3880104

21 June 2018

The "posture second" strategy: a review of wrong priorities in Parkinson's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3880104

21 June 2018

Development of a common outcome data set for fall injury prevention trials: the Prevention of Falls Network Europe consensus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3880104

21 June 2018

A global clinical measure of fitness and frailty in elderly people

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3880104

21 June 2018

Gait variability: methods, modeling and meaning

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3880104

21 June 2018

Rivastigmine for dementia associated with Parkinson's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3880104

21 June 2018

A physiological profile approach to falls risk assessment and prevention.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3880104

21 June 2018

A longitudinal evaluation of patients' perceptions of Parkinson's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3880104

21 June 2018

Frailty in older adults: evidence for a phenotype

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3880104

21 June 2018

The FAB: a Frontal Assessment Battery at bedside.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3880104

21 June 2018

The EQ-5D--a generic quality of life measure-is a useful instrument to measure quality of life in patients with Parkinson's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3880104

21 June 2018

The sydney multicentre study of Parkinson's disease: progression and mortality at 10 years

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3880104

21 June 2018

Gait changes in older adults: predictors of falls or indicators of fear.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3880104

21 June 2018

Alzheimer disease, attention, and the cholinergic system

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3880104

21 June 2018

The Physical Activity Scale for the Elderly (PASE): development and evaluation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3880104

21 June 2018

Parkinson's disease: neuron loss in the nucleus basalis without concomitant Alzheimer's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3880104

21 June 2018

Caregiver-burden in parkinson's disease is closely associated with psychiatric symptoms, falls, and disability.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-13-188

21 January 2018

How common are complications of Parkinson's disease?

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-13-188

21 January 2018

The Sydney multicenter study of Parkinson's disease: the inevitability of dementia at 20 years

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-13-188

21 January 2018

Loss of cholinergic neurons in the pedunculopontine nucleus in Parkinson's disease is related to disability of the patients.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-13-188

21 January 2018

The morphological basis of mental dysfunction in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-13-188

21 January 2018

Dementia in Parkinson disease: functional imaging of cholinergic and dopaminergic pathways

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-13-188

21 January 2018

Galantamine improves gait performance in patients with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-13-188

21 January 2018

The Cognitive Failures Questionnaire (CFQ) and its correlates.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-13-188

21 January 2018

Three simple clinical tests to accurately predict falls in people with Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-13-188

21 January 2018

Development and initial validation of the Iconographical Falls Efficacy Scale.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-13-188

21 January 2018

Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Scale presentation and clinimetric testing results

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-13-188

21 January 2018

Alzheimer Disease, Attention, and the Cholinergic System

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-13-188

21 January 2018

Effects of cognitive challenge on gait variability in patients with Parkinson's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/24299497

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

1 reference

https://pubmed.ncbi.nlm.nih.gov/24299497

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fracture rates in Parkinson's disease compared with age- and gender-matched controls: a retrospective cohort study

1 reference

https://pubmed.ncbi.nlm.nih.gov/24299497

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Motor complications in Parkinson's disease: ten year follow-up study

1 reference

https://pubmed.ncbi.nlm.nih.gov/24299497

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Exercise effect on dynamic stability in older women: a randomized controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/24299497

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Progression of falls in postmortem-confirmed parkinsonian disorders

1 reference

https://pubmed.ncbi.nlm.nih.gov/24299497

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical and physiological assessments for elucidating falls risk in Parkinson's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/24299497

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Falls in outpatients with Parkinson's disease: frequency, impact and identifying factors

1 reference

https://pubmed.ncbi.nlm.nih.gov/24299497

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Statistical Analysis of Efficacy in Falls Prevention Trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/24299497

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

1 reference

https://pubmed.ncbi.nlm.nih.gov/24299497

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1471-2377-13-188

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Dimensions Publication ID

1 reference

9 September 2019

https://scigraph.springernature.com/pub.10.1186/1471-2377-13-188

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q31145409&oldid=2195106173"